Charting a novel path towards Ebola virus disease preparedness: Considerations for preventive vaccination.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 39992920.
- Also identified by DOI 10.1371/journal.pmed.1004543 and PMC identifier 11849863.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In June 2024, Gavi, the Vaccine Alliance, launched a preventive vaccination program against Ebola virus disease (EVD). This marks a historic shift in the management of EVD, allowing at-risk countries across sub-Saharan Africa to request support in implementing preventive vaccination campaigns. This perspective piece shares considerations that can inform how countries approach preventive EVD vaccination and potential unintended consequences. It also provides insights into strategies for vaccines against other epidemic-prone pathogens.
Medical subject headings
- Hemorrhagic Fever, Ebola
- Vaccination
- Ebola Vaccines
- Ebolavirus
- Immunization Programs